-+ 0.00%
-+ 0.00%
-+ 0.00%

Bristol-Myers Squibb: A phase III ALOFT-IPF trial evaluating ADMILPARANT for treating idiopathic pulmonary fibrosis in adults reached a major end.

Zhitongcaijing·10/12/2026 10:57:22
Listen to the news
Bristol-Myers Squibb: A phase III ALOFT-IPF trial evaluating ADMILPARANT for treating idiopathic pulmonary fibrosis in adults reached a major end.